Literature DB >> 2553308

Variation in lymphoproliferative responses during recrudescent orofacial herpes simplex virus infections.

J P Vestey1, M Norval, S Howie, J Maingay, W A Neill.   

Abstract

Sixty-five patients with recrudescent orofacial herpes simplex virus (HSV) infections all had circulating HSV-specific antibody measured by ELISA and cell-mediated immunity (CMI) to HSV by in vitro lymphoproliferation. Thirteen control subjects with no history of HSV were negative for both tests. Thirty-three patients, repeatedly investigated during 6 to 38 months, had between 1 and 8 recrudescences each. Lymphoproliferative responses to HSV were low during recrudescence, rose to a peak a few weeks later and then declined to a positive background level. However, ELISA titres and lymphoproliferative responses to concanavalin A were high throughout, and peripheral blood mononuclear cell (PBMC) subset numbers measured by fluorescent flow cytometry remained within normal limits. During HSV lesions, depressed lymphoproliferation to HSV was abrogated by removal of CD8+ T cells from PBMC either by using a panning technique (nine patients) or by cell sorting (three patients). Reconstitution of the CD8-depleted population suppressed the lymphoproliferative response to HSV. Depletion of CD8+ T cells did not affect lymphoproliferation to HSV outwith recrudescence (four patients), nor lymphoproliferative responses to another antigen (PPD; five patients) during recrudescence. Thus, reduced lymphoproliferation to HSV during recrudescence may be due to HSV-specific CD8+ suppressor T lymphocyte function, rather than lack of HSV-responsive lymphocytes. This may result in depression of normal CMI responses to the virus during an asymptomatic recurrence allowing recrudescent lesions to develop.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2553308      PMCID: PMC1542042     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

1.  A herpes simplex skin test diagnostic antigen of low protein content from cell culture fluid.

Authors:  W A ANDERSON; E D KILBOURNE
Journal:  J Invest Dermatol       Date:  1961-07       Impact factor: 8.551

Review 2.  The host response to herpes simplex virus.

Authors:  P Wildy; P G Gell
Journal:  Br Med Bull       Date:  1985-01       Impact factor: 4.291

3.  Role of T lymphocytes in cellular immune responses during herpes simplex virus infection in humans.

Authors:  L Rasmussen; T C Merigan
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

4.  Immunity to herpes simplex virus type 2: recurrent lesions are associated with the induction of suppressor cells and soluble suppressor factors.

Authors:  T Iwasaka; J F Sheridan; L Aurelian
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

5.  Ultraviolet radiation inhibits alloantigen presentation by epidermal cells: partial reversal by the soluble epidermal cell product, epidermal cell-derived thymocyte-activating factor (ETAF).

Authors:  D N Sauder; F P Noonan; E C DeFabo; S I Katz
Journal:  J Invest Dermatol       Date:  1983-06       Impact factor: 8.551

6.  Immune response to herpes simplex virus infections: virus-specific antibodies in sera from patients with recurrent facial infections.

Authors:  H J Zweerink; L W Stanton
Journal:  Infect Immun       Date:  1981-02       Impact factor: 3.441

7.  Identification of herpes simplex virus type 1 (HSV-1) glycoprotein gC as the immunodominant antigen for HSV-1-specific memory cytotoxic T lymphocytes.

Authors:  J Glorioso; U Kees; G Kümel; H Kirchner; P H Krammer
Journal:  J Immunol       Date:  1985-07       Impact factor: 5.422

8.  Immunity to herpes simplex virus type 2. IV. Impaired lymphokine production during recrudescence correlates with an imbalance in T lymphocyte subsets.

Authors:  J F Sheridan; A D Donnenberg; L Aurelian; D J Elpern
Journal:  J Immunol       Date:  1982-07       Impact factor: 5.422

9.  Cell-mediated immunity against herpes simplex virus envelope, capsid, excreted, and crude antigens.

Authors:  K O Kalimo; I A Joronen; V K Havu
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

10.  Viral inhibition of lymphocyte proliferative responsiveness in patients suffering from recurrent lesions caused by herpes simplex virus.

Authors:  M A Wainberg; J D Portnoy; B Clecner; S Hubschman; J Lagacé-Simard; N Rabinovitch; Z Remer; J Mendelson
Journal:  J Infect Dis       Date:  1985-09       Impact factor: 5.226

View more
  4 in total

1.  Severe genital herpes infections in HIV-infected individuals with impaired herpes simplex virus-specific CD8+ cytotoxic T lymphocyte responses.

Authors:  C M Posavad; D M Koelle; M F Shaughnessy; L Corey
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

2.  Peripheral blood CD4 T-cell and plasmacytoid dendritic cell (pDC) reactivity to herpes simplex virus 2 and pDC number do not correlate with the clinical or virologic severity of recurrent genital herpes.

Authors:  Nicholas J Moss; Amalia Magaret; Kerry J Laing; Angela Shaulov Kask; Minna Wang; Karen E Mark; Joshua T Schiffer; Anna Wald; David M Koelle
Journal:  J Virol       Date:  2012-07-03       Impact factor: 5.103

Review 3.  Selective mechanisms utilized by persistent and oncogenic viruses to interfere with antigen processing and presentation.

Authors:  R Ehrlich
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

4.  Lymphoproliferative responses in recrudescent orofacial herpetic infections.

Authors:  J P Vestey; M Norval; S E Howie
Journal:  J R Soc Med       Date:  1990-05       Impact factor: 18.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.